Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 1/2012

01-01-2012 | Article

Increases in Australian cutaneous abscess hospitalisations: 1999–2008

Authors: V. L. Vaska, G. R. Nimmo, M. Jones, K. Grimwood, D. L. Paterson

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 1/2012

Login to get access

Abstract

Staphylococcus aureus is the most common cause of skin and soft tissue infections (SSTIs). Such infections have increased in several countries recently and at a time when community-associated methicillin-resistant S. aureus (CA-MRSA) strains have emerged globally. We examined changes in Australian hospitalisations for the treatment of cutaneous abscesses between 1999 and 2008, a period when increased numbers of CA-MRSA infections were being reported. National hospitalisation data for cutaneous abscess treatment (1999–2008) were examined. Hospitalisation numbers were collated and age-specific admission rates calculated and examined for changes over time. Yearly admissions for the treatment of cutaneous abscesses increased by 48%, from 8,849 (1999–2000) to 13,126 (2007–2008). The crude annual hospitalisation rate per 100,000 population rose from 46 to 62 respectively. However, increases in admission rates were limited to the 10 to 54 years age range. Incidence rate ratios (IRRs) for final versus baseline year admission rates for these age groups ranged from 1.36 (95% confidence interval [CI] 1.04–1.78) for those aged 10–14 years to 1.64 (95% CI 1.26–2.12) for those aged 45–49 years; p < 0.05. Increases in hospitalisation for cutaneous abscess treatment have occurred in Australia during the last decade. Research into the underlying causes and prevention of these infections is a public health priority.
Literature
4.
go back to reference Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, Talan DA (2006) Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 355(7):666–674. doi:10.1056/NEJMoa055356 PubMedCrossRef Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, Talan DA (2006) Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 355(7):666–674. doi:10.​1056/​NEJMoa055356 PubMedCrossRef
5.
go back to reference Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, Liassine N, Bes M, Greenland T, Reverdy ME, Etienne J (2003) Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton–Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9(8):978–984PubMed Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, Liassine N, Bes M, Greenland T, Reverdy ME, Etienne J (2003) Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton–Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9(8):978–984PubMed
6.
go back to reference Coombs GW, Nimmo GR, Pearson JC, Christiansen KJ, Bell JM, Collignon PJ, McLaws ML (2009) Prevalence of MRSA strains among Staphylococcus aureus isolated from outpatients, 2006. Commun Dis Intell 33(1):10–20PubMed Coombs GW, Nimmo GR, Pearson JC, Christiansen KJ, Bell JM, Collignon PJ, McLaws ML (2009) Prevalence of MRSA strains among Staphylococcus aureus isolated from outpatients, 2006. Commun Dis Intell 33(1):10–20PubMed
8.
go back to reference Australian Institute of Health and Welfare (AIHW) (2010) Separation, patient day and average length of stay statistics by principal diagnosis in ICD-10-AM, Australia,1998–99 to 2007–08. L02 Cutaneous abscess, furuncle and carbuncle. AIHW. Available online at: http://www.aihw.gov.au/data-cube/?id=6442475319. Accessed 26 November 2010 Australian Institute of Health and Welfare (AIHW) (2010) Separation, patient day and average length of stay statistics by principal diagnosis in ICD-10-AM, Australia,1998–99 to 2007–08. L02 Cutaneous abscess, furuncle and carbuncle. AIHW. Available online at: http://​www.​aihw.​gov.​au/​data-cube/​?​id=​6442475319. Accessed 26 November 2010
10.
13.
16.
go back to reference Munckhof WJ, Nimmo GR, Carney J, Schooneveldt JM, Huygens F, Inman-Bamber J, Tong E, Morton A, Giffard P (2008) Methicillin-susceptible, non-multiresistant methicillin-resistant and multiresistant methicillin-resistant Staphylococcus aureus infections: a clinical, epidemiological and microbiological comparative study. Eur J Clin Microbiol Infect Dis 27(5):355–364. doi:10.1007/s10096-007-0449-3 PubMedCrossRef Munckhof WJ, Nimmo GR, Carney J, Schooneveldt JM, Huygens F, Inman-Bamber J, Tong E, Morton A, Giffard P (2008) Methicillin-susceptible, non-multiresistant methicillin-resistant and multiresistant methicillin-resistant Staphylococcus aureus infections: a clinical, epidemiological and microbiological comparative study. Eur J Clin Microbiol Infect Dis 27(5):355–364. doi:10.​1007/​s10096-007-0449-3 PubMedCrossRef
17.
go back to reference Nimmo GR, Schooneveldt JM, Sutherland JL, Power S, Olesen D, Selvey C, Beard F, Jones M, Paterson DL (2010) Epidemiology of non-multiresistant methicillin-resistant Staphylococcus aureus infection in Queensland, Australia: associations with indigenous populations and Panton–Valentine leukocidin. Eur J Clin Microbiol Infect Dis 29(10):1253–1259. doi:10.1007/s10096-010-0994-z PubMedCrossRef Nimmo GR, Schooneveldt JM, Sutherland JL, Power S, Olesen D, Selvey C, Beard F, Jones M, Paterson DL (2010) Epidemiology of non-multiresistant methicillin-resistant Staphylococcus aureus infection in Queensland, Australia: associations with indigenous populations and Panton–Valentine leukocidin. Eur J Clin Microbiol Infect Dis 29(10):1253–1259. doi:10.​1007/​s10096-010-0994-z PubMedCrossRef
18.
go back to reference Muttaiyah S, Coombs G, Pandey S, Reed P, Ritchie S, Lennon D, Roberts S (2010) Incidence, risk factors, and outcomes of Panton–Valentine leukocidin-positive methicillin-susceptible Staphylococcus aureus infections in Auckland, New Zealand. J Clin Microbiol 48(10):3470–3474. doi:10.1128/JCM.00911-10 PubMedCrossRef Muttaiyah S, Coombs G, Pandey S, Reed P, Ritchie S, Lennon D, Roberts S (2010) Incidence, risk factors, and outcomes of Panton–Valentine leukocidin-positive methicillin-susceptible Staphylococcus aureus infections in Auckland, New Zealand. J Clin Microbiol 48(10):3470–3474. doi:10.​1128/​JCM.​00911-10 PubMedCrossRef
19.
go back to reference Maree CL, Eells SJ, Tan J, Bancroft EA, Malek M, Harawa NT, Lewis MJ, Santana E, Miller LG (2010) Risk factors for infection and colonization with community-associated methicillin-resistant Staphylococcus aureus in the Los Angeles County jail: a case–control study. Clin Infect Dis 51(11):1248–1257. doi:10.1086/657067 PubMedCrossRef Maree CL, Eells SJ, Tan J, Bancroft EA, Malek M, Harawa NT, Lewis MJ, Santana E, Miller LG (2010) Risk factors for infection and colonization with community-associated methicillin-resistant Staphylococcus aureus in the Los Angeles County jail: a case–control study. Clin Infect Dis 51(11):1248–1257. doi:10.​1086/​657067 PubMedCrossRef
20.
go back to reference Hayward A, Knott F, Petersen I, Livermore DM, Duckworth G, Islam A, Johnson AM (2008) Increasing hospitalizations and general practice prescriptions for community-onset staphylococcal disease, England. Emerg Infect Dis 14(5):720–726PubMedCrossRef Hayward A, Knott F, Petersen I, Livermore DM, Duckworth G, Islam A, Johnson AM (2008) Increasing hospitalizations and general practice prescriptions for community-onset staphylococcal disease, England. Emerg Infect Dis 14(5):720–726PubMedCrossRef
21.
go back to reference Edelsberg J, Taneja C, Zervos M, Haque N, Moore C, Reyes K, Spalding J, Jiang J, Oster G (2009) Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis 15(9):1516–1518PubMedCrossRef Edelsberg J, Taneja C, Zervos M, Haque N, Moore C, Reyes K, Spalding J, Jiang J, Oster G (2009) Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis 15(9):1516–1518PubMedCrossRef
22.
go back to reference Klein E, Smith DL, Laxminarayan R (2007) Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999–2005. Emerg Infect Dis 13(12):1840–1846PubMed Klein E, Smith DL, Laxminarayan R (2007) Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999–2005. Emerg Infect Dis 13(12):1840–1846PubMed
23.
go back to reference Saxena S, Thompson P, Birger R, Bottle A, Spyridis N, Wong I, Johnson AP, Gilbert R, Sharland M (2010) Increasing skin infections and Staphylococcus aureus complications in children, England, 1997–2006. Emerg Infect Dis 16(3):530–533PubMedCrossRef Saxena S, Thompson P, Birger R, Bottle A, Spyridis N, Wong I, Johnson AP, Gilbert R, Sharland M (2010) Increasing skin infections and Staphylococcus aureus complications in children, England, 1997–2006. Emerg Infect Dis 16(3):530–533PubMedCrossRef
Metadata
Title
Increases in Australian cutaneous abscess hospitalisations: 1999–2008
Authors
V. L. Vaska
G. R. Nimmo
M. Jones
K. Grimwood
D. L. Paterson
Publication date
01-01-2012
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 1/2012
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-011-1281-3

Other articles of this Issue 1/2012

European Journal of Clinical Microbiology & Infectious Diseases 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.